Contract Liabilities
Moderna Contract Liabilities increased by 0.7% to $154.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 165.5%, from $58.00M to $154.00M. Over 5 years (FY 2020 to FY 2025), Contract Liabilities shows a downward trend with a -2.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong future revenue visibility and customer demand, while a decrease may indicate faster fulfillment or slowing sales.
Detailed definition
This represents the obligation to transfer goods or services to a customer for which the company has already received co...
Peer comparison
Common in companies with long-term service contracts or subscription-based diagnostic models; peers with high recurring revenue often show higher balances.
contract_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.00M | $498.00M | $615.00M | $464.00M | $405.00M | $175.00M | $673.00M | $673.00M | $692.00M | $166.00M | $83.00M | $58.00M | $95.00M | $95.00M | $58.00M | $58.00M | $65.00M | $157.00M | $153.00M | $154.00M |
| QoQ Change | — | +184.6% | +23.5% | -24.6% | -12.7% | -56.8% | +284.6% | +0.0% | +2.8% | -76.0% | -50.0% | -30.1% | +63.8% | +0.0% | -38.9% | +0.0% | +12.1% | +141.5% | -2.5% | +0.7% |
| YoY Change | — | — | — | — | +131.4% | -64.9% | +9.4% | +45.0% | +70.9% | -5.1% | -87.7% | -91.4% | -86.3% | -42.8% | -30.1% | +0.0% | -31.6% | +65.3% | +163.8% | +165.5% |
Product Breakdown
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| Grant revenue | $3.00M | $2.00M | $4.00M | $4.00M | $4.00M | $4.00M | $11.00M | $9.00M |
| Licensing and royalty revenue | — | — | — | $0.00 | — | $20.00M | $13.00M | $8.00M |
| Collaboration revenue | $73.00M | $62.00M | $41.00M | $34.00M | $33.00M | $33.00M | $7.00M | — |
| Total | $673.00M | $692.00M | $166.00M | $83.00M | $58.00M | $95.00M | $95.00M | $58.00M |
Collaboration revenue, Grant revenue, Licensing and royalty revenue were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Contract Liabilities at Other Companies
Frequently Asked Questions
- What is Moderna's contract liabilities?
- Moderna (MRNA) reported contract liabilities of $154.00M in Q1 2026.
- How has Moderna's contract liabilities changed year-over-year?
- Moderna's contract liabilities increased by 165.5% year-over-year, from $58.00M to $154.00M.
- What is the long-term trend for Moderna's contract liabilities?
- Over 5 years (2020 to 2025), Moderna's contract liabilities has grown at a -2.9% compound annual growth rate (CAGR), from $177.00M to $153.00M.
- What does contract liabilities mean?
- Money received from customers for products or services that have not yet been delivered.